Contract Pharmaceutical News: Breaking Contract Pharmaceutical News, Comments and Articles. - Page: 3

Guided Therapeutics Reports First Quarter 2013 Results

Key Highlights: Initial Edition 3 CE Marked LuViva® Advanced Cervical Scan unit shipped LuViva® featured at major medical scientific meetings Clinical trial results to be published in journal Gynecologic Oncology Awaiting FDA Response Guided Therapeutics, Inc. (OTCBB: GTHP...

Houses.com Cites More Millennials Buying Homes Before Marriage

Recent findings by eReal Estate Holding's portal Houses.com, are showing that young couples today are more likely to buy a home before getting married. Such "engagement houses" on the rise in the Northeast especially. Miami, FL (PRWEB) May 14, 2013 Recent studies are showing that young couples today are more likely to buy a home before getting married. Based on a random sampling of...

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

Large scale manufacturing contract revenue in the first quarter of 2013 increased 14% over the same quarter in 2012 as AMRI (Albany Medical Research Inc.) saw an 11% increase in overall revenue. 

Natural Alternatives International, Inc. Announces Fiscal 2013 Q3 and YTD Results

SAN MARCOS, Calif., May 14, 2013 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $178,000 or $0.03 per diluted share on net sales of $15.8 million for the quarter ended March 31, 2013.  Net sales for the three months ended March 31, 201...

GlaxoSmithKline big pharma deals with DKSH for antibiotics

Big pharma company, GlaxoSmithKline, has signed a pharma deals agreement with DKSH for them to provide contract sales services in both private clinics and trade channel for the big pharma company’s antibiotic product line.  DKSH’s Business Unit Healthcare in Hong Kong has the largest sales team in the industry to provide pharma deals, sales and [...]The post GlaxoSmithKline big pharma dea...

Tawuniya and Aetna Form Strategic Alliance

The Company for Cooperative Insurance (Tawuniya), and Aetna (NYSE: AET), a leading global diversified health care solutions company, have entered into a strategic alliance to provide health care benefits and services to Saudi citizens in the Kingdom of Saudi Arabia or abroad and to foreign nationals living in the Kingdom.

CMC Biologics and RuiYi link on MAb; Deal for Cynviloq rights in EU

Denmark and USA-based contract manufacturers CMC Biologics has entered into an agreement with China's RuiYi to develop a cell line for RYI-008, a novel anti-inteleukin-6 monoclonal antibody. CMC Biologics' proprietary CHEF1 high-productivity expressi...

AEGY Announces Acquisition of Medical Cannabis Marketing Company

LOS ANGELES, May 14, 2013 /PRNewswire/ -- Alternative Energy Partners, Inc. (OTCBB: AEGY) announces that it has signed a definitive agreement to acquire the PharmaJanes™ marketing operation from iEquity Corp. and will be changing its business model to focus purely in the medical marijuana marketing space.  AEGY will be changing its name to PharmaJanes, Inc and will no longer move f...

GSK deal aims to grow business in Asia

DKSH's Business Unit Healthcare, a market expansion services provider for healthcare companies seeking to grow their business in Asia, has signed an agreement with GlaxoSmithKline to provide contract sales services in both private clinics and trade c...

GSK and Kyowa Hakko Latest to Ink SE Asia Deals with DKSH

In another contract with Big Pharma in Asia, DKSH has penned a contract sales deal with GlaxoSmithKline.

Valence Health Announces New Vice President of Client Implementations, Lisa Lerma

Industry leader with nearly two decades of experience in healthcare operations joins clinical integration consultancy firm Valence Health, a leading provider of clinical integration, population health and value-based care analytics and services, today announced that industry veteran, Lisa Lerma, joined the company as Vice President of Client Imp...

Ephraim McDowell Health Expands Contract with HealthCare Anytime™ to Include Full Enterprise Patient Portal Suite

HealthCare Anytime™, a leading provider of enterprise patient portal technology, announced today that it has expanded its current contract with Ephraim McDowell Health to include its entire enterprise patient portal suite. The new features of the full suite will provide patients with the meaningful online experience needed to drive patient engagement. Ep...

Frazier Healthcare and PCI acquire AndersonBrecon

Combined business will create the largest global pharmaceutical contract packer

ClearPath Workforce Management ranked among nations Top 100 woman-owned businesses

Listed in the Div500 as among the nation’s most successful privately owned businesses by DivsityBusiness.com Mountain View, California (PRWEB) May 14, 2013 ClearPath Workforce Management, a leading HRO with a focus on contingent workforce management solutions, announced today that it has again been acknowledged by DiversityBusiness.com as among the nation’s most successful privately owned bus...

Data Sciences International (DSI) in Space

DSI Technology Used to Study Mice in Russian Space Mission St. Paul, MN (PRWEB) May 14, 2013 Data Sciences International (DSI) has taken part in an exciting study involving its products traveling to space. DSI was approached nearly four years ago by a European researcher working in collaboration with the European Space Agency and the Russian Space Agency on a study measuring the effects space tr...

CMC Biologics and RuiYi Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody

SEATTLE, COPENHAGEN, Denmark and SHANGHAI, May 14, 2013 /PRNewswire/ -- CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody. CMC Biologics' proprietary CHEF1® high-productivity expression plasmid will be utilized for the cell line development to optimize cell growth, and consistent, high-level pr...

BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013

BOTHELL, Wash., May 14, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record revenue for the first quarter of 2013 of $2.2 million, including license revenue of $0.6 mill...

Smiths Medical secures contract to supply ViaValve Safety IV Catheters

Smiths Medical, a medical device manufacturer, has secured a contract with the US Department of Veterans Affairs to supply Jelco brand ViaValve Safety IV Catheters to the Raymond G. Murphy VA Medical Center, New Mexico, US.

Novatus Contract Management Teams Up with DocuSign to Empower Companies to Keep Business Digital

San Francisco, CA and Orlando, FL (PRWEB) May 14, 2013 Novatus Contract Management announced today it is teaming up with DocuSign, The Global Standard for eSignature®, to empower companies to keep business digital. Novatus Contract Management...

Quick-Med Announces Expanded Global Distribution of Advanced Dressings With NIMBUS ® Technology

GAINESVILLE, FL--(Marketwired - May 14, 2013) - Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that Viridis BioPharma Pvt. Ltd. has been granted an expanded license to sell Microfoam™ dressings. Microfoam is the first advanced wound care dressing to utilize Quick-Med's propr...

Kemwell Expands Capabilities in India

Adds analytical equipment and scientists for FTE contract

ComInnex Aims to Create Novel Chemicals for Pharmaceutical, Cosmetics and Fine Chemical Applications

BUDAPEST, HUNGARY -- (Marketwired) -- 05/14/13 -- ComInnex, Inc., a privately held contract research and integrated discovery chemistry service organization announced today that its innovative project, "Development of a flow chemistry and pyrolysis platform for pharmaceutical, cosmetics and agrochemical applications in combination with novel nanoformulation processes," gained support from the Na...

NBTY Private Label Business Woes Prompt Facilities Restructuring

The nutritional products firm is ceasing operations at several domestic locations, mainly involved in private label and contract manufacturing, likely pressed by owner The Carlyle Group to shrink its footprint and cut costs. NBTY expects to absorb be...

Tetraphase Reports First Quarter 2013 Financial Results

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the first quarter ended March 31, 2013. "Following our successful initial public offering in March 2013, Tetraphase is well positioned to advance our lead candidate eravacycline for the treatment of multi-drug resistant infections, particularly difficult-to-treat s...

Chiltern Announces Senior Appointments Aimed At Securing The Company's Continued Success And Future Growth

LONDON and WILMINGTON, N.C., May 13, 2013 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announces the appointments of Dr Manuela Niewel and Lisa Bull to secure Chiltern's continued success and future growth. Dr Manuela Niewel has been appointed Medical Director to serve as therapeutic expert in the oncology area in the medical department...